Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Aptamer Group (APTA) Share News

Aptamer shares plummet as revenue falls, recquires further funding

4th Jul 2023 09:31

(Alliance News) - Aptamer Group PLC on Tuesday said its expected annual revenue dropped and is seeking additional funding to ensure its survival. Read More

LONDON MARKET OPEN: Tepid trade as housebuilders weigh on FTSE 100

4th Jul 2023 08:50

(Alliance News) - London's FTSE 100 tread water in early dealings on Tuesday, with housebuilders on the back foot, and little movement elsewhere during what is expected to be a muted day for global markets due to a thin data calendar and a US holiday. Read More

IN BRIEF: Aptamer notes share jump, not aware of reason for rise

14th Jun 2023 13:41

Aptamer Group PLC - York, England-based company which develops custom affinity binders through its Optimer platform to enable new approaches in therapeutics, diagnostics and research applications - Notes "significant increase" in share price. Says, aside from announcement earlier, not aware of other reason for share jump. Read More

LONDON MARKET MIDDAY: FTSE 100 up; Vodafone unveils UK mobile merger

14th Jun 2023 12:17

(Alliance News) - The FTSE 100 index was higher at midday in London on Wednesday, buoyed by market confidence that the US Federal Reserve will hold interest rates steady later in the day, as well as a major merger announcement from telecommunications firm Vodafone. Read More

AIM WINNERS & LOSERS: Aptamer soars on Alzheimer's test success

14th Jun 2023 09:50

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More

Aptamer shares soar after success in rapid Alzheimer test development

14th Jun 2023 09:25

(Alliance News) - Aptamer Group PLC said on Wednesday that it has partnered with Neuro-Bio Ltd and declared success in the development of a lateral flow test to diagnose early Alzheimer's disease. Read More

IN BRIEF: Aptamer CEO Arron Tolley resigns with immediate effect

10th May 2023 12:08

Aptamer Group PLC - York, England-based company that develops custom affinity binders through its Optimer platform to enable new approaches in therapeutics, diagnostics and research applications - Chief Executive Officer Arron Tolley leaves his position and the board immediately. Tolley will remain with Aptamer for a period of garden leave. Chair Ian Gilham will become executive chair, and Chief Financial Officer Rob Quinn will take on the additional role of interim CEO. Aptamer will "immediately" begin search for a full-time CEO. Read More

LONDON MARKET CLOSE: Surprise US jobs report lifts market mood

5th May 2023 17:03

(Alliance News) - Stocks in London were higher at the close on Friday, ahead of a long bank holiday weekend, as the latest US jobs report made a recession across the Atlantic appear less likely. Read More

LONDON MARKET MIDDAY: Stocks pare weekly losses ahead of US nonfarms

5th May 2023 12:08

(Alliance News) - Stock prices in London were higher at midday on Friday, a better end to a nervy week for equities, with investors digesting central bank decisions and an ongoing crisis in the US regional banking sector. Read More

Aptamer expects annual revenue drop after pipeline conversion issues

5th May 2023 12:06

(Alliance News) - Aptamer Group PLC said on Friday it expects "significantly lower" revenue for this financial year and blamed figures for the past ten months on slower-than-expected conversion of its pipeline. Read More

AIM WINNERS & LOSERS: Aptamer says struggling to convert pipeline

5th May 2023 11:11

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More

Aptamer meets need for patentable reagents with launch of Optimer-Fc

20th Mar 2023 11:21

(Alliance News) - Aptamer Group PLC on Monday expanded its Optimer binder pipeline with the launch of Optimer-Fc, a new reagent solution for immunohistochemistry. Read More

EARNINGS SUMMARY: Eagle Eye profit up; Litigation Capital optimistic

14th Mar 2023 17:39

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

7th Mar 2023 15:44

Read More

IN BRIEF: Aptamer appoints Rob Quinn as new chief financial officer

13th Feb 2023 07:51

Aptamer Group PLC - York, England-based company which develops custom affinity binders through its Optimer platform to enable new approaches in therapeutics, diagnostics and research applications - Appoints Rob Quinn as chief financial and as an executive director of the board, effective from March 1. Quinn was previously CFO at Pharnext, a biotech company in Paris. Read More

Aptamer signs GBP185,000 contract extension to develop Optimer binders

30th Jan 2023 14:10

(Alliance News) - Aptamer Group PLC on Monday said it has signed a follow on deal to develop Optimer binders as novel solutions for a direct-to-consumer personal care product. Read More

Aptamer Group signs two new contracts worth over GBP500,000

24th Jan 2023 10:46

(Alliance News) - Aptamer Group PLC on Tuesday celebrated a "solid start" to the second half, after signing two new contracts with the potential for downstream milestone and licencing payments. Read More

Aptamer warns on full-year revenue as headwinds continue into 2023

3rd Jan 2023 13:18

(Alliance News) - Aptamer Group PLC on Tuesday warned it will miss its full-year revenue target, as headwinds continued into the new financial year. Read More

TRADING UPDATES: XLMedia, Mobile Streams and Windar win deals

1st Dec 2022 12:59

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: Aptamer opens news site to aid demand for Optimer technology

25th Nov 2022 10:46

Aptamer Group PLC - York, England-based provider of custom services, diagnostics and therapeutics for biotechnology and pharmaceutical firms - Opens its new 18,000 square feet facilities in York Science Park in the UK. Says the facilities will allow the company to meet the increasing demand for optimer technology. "This state-of-the-art site will help to expand the capacity of Aptamer's proprietary Optimer platform to deliver novel binders for scientists across the bioprocessing, diagnostic, and drug development sectors," Aptamer notes. Read More

FTSE 100 Latest
Value8,809.74
Change53.53